KVK. S. Veliev

K. S. Veliev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


K. S. Veliev has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Long-term results of mini-gastric bypass surgery with different biliary loop lengths in obese patients

    by A. G. Khitaryan, K. S. Oplimah, D. A. Melnikov, A. V. Mezhunts, K. S. Veliev, D. Yu. Pukovsky, E. A. Kizhevatova, V. P. Evdokimov, А. Г. Хитарьян, К. С. Оплимах, et al.

    INTRODUCTION. The study of mini-gastric bypass surgery outcomes with different lengths of the biliopancreatic limb is essential for optimizing restrictive and malabsorptive components, as well as for assessing the risk of adverse outcomes such as insufficient weight loss, weight regain, malabsorption, or sarcopenia development. The OBJECTIVE was to evaluate outcomes in patients with morbid obesity with different lengths of the biliopancreatic limb (170 cm and 210 cm). METHODS AND MATERIALS. A prospective cohort study was conducted involving 192 patients divided into two groups using simple randomization. All patients underwent mini-gastric bypass surgery with different lengths of the biliopancreatic limb. Results were assessed 36 months after surgery, analyzing anthropometric indicators, biochemical markers, and complication rates. RESULTS. No statistically significant differences were found between the groups in the main indicators. The median excess weight loss was 81 % in the first group and 80 % in the second. Diabetes remission was achieved in 79.1 % and 81.4 % of patients, respectively. It was noted that the effectiveness of the surgery depends not on the absolute length of the limb but on the ratio of the excluded segment to the total small intestine length. CONCLUSIONS. The study showed no statistically significant differences between the 170 cm and 210 cm biliopancreatic limb lengths regarding major biochemical and clinical indicators. Thus, the study confirms the need for a personalized approach in bariatric surgery.

  • Open Access

    Personalization of heparin therapy in bariatric patients using thrombodynamic testing

    by A. G. Kitaryan, A. A. Orekhov, M. V. Gulyan, K. V. Lobastov, K. S. Veliev, A. S. Egorova, A. G. Osmanian, V. V. Ksenofontov, A. S. Gasparian, A. D. Studenikin, et al.

    Introduction. Morbid obesity is associated with a high risk of venous thromboembolic complications (VTE) after bariatric surgery; however, standard risk stratification scales do not always provide sufficient predictive accuracy for this patient population, and monitoring the efficacy of anticoagulant prophylaxis remains challenging. Aim. To evaluate the use of thrombodynamics assay for assessing the risk of VTE in patients with morbid obesity undergoing bariatric surgery, stratified according to the modified Caprini-B score, and to analyze the dynamics of hemostasis parameters during anticoagulant prophylaxis. Materials and methods. A prospective observational study included 113 patients with morbid obesity (BMI 44.5 ± 8.0 kg/m2) who underwent laparoscopic bariatric procedures. Patients were divided into two groups: moderate risk (7–11 points on the Caprini-B score, n = 63) and high risk (≥12 points, n = 50). VTE prophylaxis was performed with nadroparin calcium (38–57 anti-Xa IU/kg) for at least 21 days. Thrombodynamics assay was performed before surgery, immediately after surgery, and on postoperative day 4. Results. No clinically significant VTE events were registered in either group. In high-risk patients, baseline hypercoagulation was detected (clot growth velocity V – 33.0 ± 2.5 μm/min vs. normal range 20–29 μm/min, p < 0.05), which increased after surgery. By day 4, nadroparin therapy achieved normocoagulation in the moderate-risk group; in the high-risk group, hypercoagulation decreased and stabilized at the upper limit of normal. No hemorrhagic complications were observed. Conclusions. Thrombodynamics assay provides an objective assessment of hemostasis in bariatric patients and enables monitoring of anticoagulant prophylaxis efficacy. The most informative parameters are clot growth velocity and clot size (V, Vst, CS). In patients with ≥12 points on the Caprini-B score, hypercoagulation persists at the upper normal limit by day 4, which may require extended or intensified anticoagulant therapy

  • Open Access

    The experience of using photodynamic therapy in the complex treatment of venous ulcers

    by A. G. Khitaryan, I. P. Chumburidze, M. Yu. Shtilman, A. A. Orekhov, K. S. Veliev, A. A. Pirogov, A. G. Osmanian, Z. I. Potokova, A. S. Gasparian, E. V. Andreev

    Introduction . A promising direction in the management of venous leg ulcers is photodynamic therapy (PDT), which is based on the use of photosensitizers that selectively accumulate in pathological tissues. Upon exposure tolight of a specific wavelength, reactive oxygen species are generated,leading to the destruction of damaged cells, stimulation of tissue regeneration, and exerting an antimicrobial effect. Aim . To evaluate the treatment outcomes of patients with venous ulcers using PDT. Materials and methods . An analysis was conducted on the treatment outcomes of 49 patients, including 33 men (67.3%). The patients were aged between 51 and 76 years. All 49 individuals had a history of post-thrombotic syndrome, and the duration of the ulcerative defect exceeded six months. In 23 patients, treatment was carried out using conventional therapeutic methods. In 26 cases,locallaser exposure was added to the treatment regimen, following the application of the photosensitizing agent Photoditazine to the wound surface. Results . During treatment, the level of microbial contamination decreased in both groups. However, patients in the study group showed a more rapid decrease starting as early as the 4th day of hospitalization. By the 8th day, this indicator was significantlylower in patients in the study group. Similar trends were also recorded on the 12th day of the study. An earlier transition to the regenerative type of cytogram was observed in patients receiving PDT, along with the formation of new granulation tissue by day 12. Conclusions . The obtained results confirm the clinical feasibility of using PDT in the treatment of patients with venous ulcers.

  • Prediction of postoperative complications in patients after bariatric surgery with using the artificial intelligence

    by А. G. Khitaryan, A. V. Mezhunts, K. S. Veliev, A. A. Orekhov, D. A. Melnikov, O. S. Pen, D. Yu. Pukovsky, A. G. Osmanian, Z. I. Potokova, A. S. Gasparian

    The OBJECTIVE was to develop, validate, and implement a clinical and laboratory model based on machine learning (ML) for the early identification and timely prevention of postoperative complications in patients who have undergone bariatric surgery.METHODS AND MATERIALS. A retrospective analysis was performed on clinical data from 2,011 patients who underwent bariatric procedures. The study included demographic characteristics, clinical symptoms, laboratory findings, imaging results, and details of the postoperative course. A logistic regression model was constructed using automatic class weighting to correct for class imbalance and improve predictive accuracy. The model’s performance was evaluated using key metrics: AUC, accuracy, sensitivity, specificity, and F1-score.RESULTS. The developed model demonstrated high predictive performance (AUC=0.975, accuracy=94.8 %, sensitivity=93.1 %). The most significant predictors of postoperative complications were elevated C-reactive protein levels, tachycardia, fever, symptom severity, and inflammatory laboratory markers.CONCLUSION. The proposed machine learning model shows substantial potential for integration into clinical practice and may serve as a foundation for developing intelligent systems for early complication warning, automated monitoring, and clinical decision support.

  • Open Access

    Obesity and chronic venous diseases as comorbid pathologies in surgical practice

    by A. G. Khitar’yAn, A. A. Orekhov, E. Ya. Kirtanasova, V. N. Kislyakov, A. V. Mezhunts, K. S. Veliev

    This review is devoted to the modern view of morbid obesity in the development and treatment of chronic venous diseases (CVD) and includes a compilation of data from domestic and foreign literature, including clinical recommendations of WHO and the Russian Ministry of Health. Currently, there is evidence of an aggravating association of morbid obesity (BMI ≥ 40 kg/m2 or with BMI ≥ 35 kg/m2 in the presence of serious complications associated with obesity) with CVD, while both conditions are widespread in the world with a tendency to progress. Often they exist simultaneously in the patient, which increases the risk of vascular events and radically changes the management tactics of such a patient. The outcomes of developing remodeling in the walls of the veins in the form of, first of all, an inflammatory process are reflected in the arterial bed, which increases the relevance of the issue and emphasizes the need for timely correction and, mainly, adequate surgical treatment. The results of various surgical interventions at venous incompetence worsen along with an increase in BMI. In this regard, today, patients with extremely (≥40 kg/m2) high BMI are primarily recommended to treat not venous insufficiency, but to correct weight, including through bariatric surgery, which is due to the ineffectiveness of the reverse approach.

  • Open Access

    Hemodynamic sclerotherapy in comprehensive management of varicose disease of lower-limb veins in patients with morbid obesity

    by A. G. Khitaryan, E. Ya. Kirtanasova, A. A. Orekhov, D. A. Gusarev, V. N. Kislyakov, K. S. Veliev, I. P. Chumburidze, D. V. Shatov

    Introduction. Endovenous laser ablation combined with sclerotherapy are effective treatment options for varicose veins of the lower limb. However, sclerotherapy is associated with an increased risk of side effects in patients with morbid obesity, which makes it challenging.Aim. To improve efficiency of the varicose veins of the lower limb treatment in patients with morbid obesity by using the aspects of “hemodynamic sclerotherapy”.Materials and methods. Prospective comparative study included 109 patients with C3–C5 classes of chronic venous diseases and morbid obesity was performed. All patients were treated with endovenous laser ablation combined with sclerotherapy. In the main group (n = 56) sclerotherapy was performed in the Trendelenburg position, in the control group (n = 53) – in the horizontal position.Results. The diameter reduction of the great saphenous vein by 22.5% in the Trendelenburg position with 15° incline was statically significant (p < 0.001). The perforating veins reflux in the Trendelenburg position with 15° incline was not detected in 72.3% of patients (p < 0.001). The occlusion rates of the varicose tributaries not treated with sclerosant in the main group was 41% (p = 0.032). In the main group only 12.5% of patients were found to have phlebitis (p = 0.029), the Visual Analog Score (p = 0.036) and local temperature (p = 0.049) were also significantly lower. The incomplete occlusion rate of the varicose tributaries in the main group was only 5.3%; however, the difference was not statically significant.Discussion. The perforating veins reflux in the Trendelenburg position and the incomplete occlusion of the varicose tributaries were only in obese patients with body mass index more than 55 kg/m2 and C4b–C5 classes.Conclusions. Sclerotherapy in the Trendelenburg position with the legs elevated at least 15° incline improves the efficiency of the varicose vein’s occlusion in patients with morbid obesity. Sclerotherapy in obese patients with body mass index more than 55 kg/m2 has less effect.


  • Open Access

    The effectiveness of minimally invasive surgical techniques for treating patients with chronic venous insufficiency in the stage of trophic disorders: comparative study

    by A. G. Khitaryan, K. S. Veliev

    Introduction. Despite the active introduction of minimally invasive techniques into modern phlebology, the problem of surgical treatment of chronic venous insufficiency (CVI) in the stage of trophic disorders is still far from being finally resolved, especially problems of horizontal reflux. Aim. Тo comparatively evaluate the results of using various tactics of minimally invasive surgical treatment in patients with lower extremitiesʹs CVI in the stage of trophic disorders.Materials and methods. A study at 139 patients with CVI at the stage of trophic disorders was carried out. Group 1 (n = 79) included patients who underwent endovasal laser coagulation of the trunks of the great and small saphenous veins (GSV and SSV) with microfoam sclerotherapy of varicose perforating veins. In group 2 (n = 60) – method of intervention was determined by the diameter of Cockettʹs perforants.Results. Indicators of the early postoperative period in the study groups were comparable. After 2 months, no cases of relapse in the GSV and SSV were registered. Recurrence of horizontal reflux was observed only in 6 (7.6%) people in group 1. In long-term postoperative follow-up, decrease in the severity of the disease according to the VCSS scale was found in both groups (p < 0.001). The persistence of pathological reflux along was observed in 16 (22.5%) patients of group 1. Moreover, in 62.5% and 68.75% cases of relapses, the perforants had, respectively, a large diameter and high blood flowʹs speed.Discussion. In general, minimally invasive techniques used demonstrated comparable clinical results and high efficiency. At the same time, the importance of preoperative assessment and taking into account the properties of perforants has been proven.Conclusion. The claimed method should be considered as an effective and safety method of obliteration of incompetent perforating veins at severe forms of CVI.

  • Open Access

    The first experience of robot-assisted vental mesh rectopexy using the Senhance® system in the treatment of patients with obstructive defecation syndrome

    by A. G. Khitaryan, A. A. Golovina, K. S. Veliev, A. V. Mezhunts, A. Z. Alibekov, A. A. Orekhov, V. A. Khitaryan, K. S. Oplimah

    Aim: to assess primary results of robot-assisted ventral mesh procedure using the new Senhance® robotic system for obstructive defecation syndrome.Patients and Methods: the prospective cohort study included patients who underwent robot-assisted ventral mesh rectopexy with the Senhance® system for obstructive defecation syndrome caused by rectocele and/or rectal prolapse and/or internal intussusception. The optimal trocar sites, the location of robotic arms, operation time and intraoperative blood loss were evaluated, as well as post-op morbidity rate (Clavien-Dindo scale), pain intensity (VAS scale) and recurrence rate.Results: the study included 22 patients. Operation time was 87.1 ± 24.3 minutes. The intraoperative blood loss was 19.8 ± 9.6 ml. No conversion to open or laparoscopic approach occurred, no morbidity occurred. Pain intensity on day 1 was 0.255 mm according to VAS. No anatomical recurrence was revealed. The median follow-up period was 20.4 months (7–22 months).Conclusion: robotic-assisted ventral rectopexy using the Senhance® system is effective and safe. The results are similar to laparoscopic ones. However, the use of the Senhance® system is cost effective compared to other robotic systems.


  • Open Access

    Modern approaches to the treatment of trophic ulcers of venous etiology: photodynamic therapy

    by A. G. Khitaryan, A. A. Ledenev, A. A. Orekhov, K. S. Veliev, V. A. Lyapina, V. V. Kuznetsova, V. N. Bondarenko

    Chronic venous insufficiency, being the outcome and complication of most diseases of the veins of the lower extremities, is the fundamental cause of the formation of trophic ulcers. Over the past decade, in solving the problem of treating venous trophic ulcers, certain successes have been achieved, both in theoretical and practical terms. The modern concept of curation of patients with trophic ulcers of venous origin involves a reasonable combination of the following methods of treatment: local, including compression, as well as medical, surgical, minimally invasive and additional methods (physiotherapy, photodynamic therapy, etc.). The main goal of the treatment is to eliminate the ulcer, after which measures are taken to correct the underlying cause (chronic venous insufficiency) and prevent relapse. However, the tactics of the most successful treatment of patients with trophic ulcers of venous etiology is still not defined and requires further improvement. In particular, the method of photodynamic therapy, which includes the usage of special drugs - photosensitizers, also deserves to be studied and expanded for clinical use. The mechanism of photodynamic action is based on the ability of photosensitizers to accumulate in microbial and pathological cells. Under local light exposure, the photosensitizer enters an excited state and charges oxygen, which is associated with erythrocyte hemoglobin. Thus, in cells under the influence, a photochemical reaction is triggered, which ensures the formation of singlet oxygen and its free radicals. Reactive oxygen species, in turn, have a damaging effect on pathogenic flora and necrotic tissues. The main advantages of the method are relative simplicity, no risk of developing antibiotic resistance, acceleration of reparative and regenerative processes, and prevention of secondary infection. Thus, photodynamic therapy allows non-invasive, safe and effective optimization of local treatment and preoperative preparation of patients with venous trophic ulcers.


  • The first experience of robot-assisted bariatric surgery using the Senhance system in patients with morbid obesity

    by A.G. Khitaryan, A.V. Mezhunts, K.S. Veliev, D.A. Melnikov, A.A. Abovyan, A.A. Rogut

    Objective. To study the results of robot-assisted bariatric surgery using the Senhance system in patients with morbid obesity. Material and methods. A prospective cohort study included 74 patients who underwent bariatric surgery (Senhance digital laparoscopy system) between January 2022 and May 2023. Of these, 12 patients underwent robot-assisted longitudinal gastrectomy, 20 patients — robot-assisted Roux-en-Y gastric bypass, 36 patients — robot-assisted gastric bypass with one anastomosis/mini-gastric bypass, 6 patients — surgical exploration. We assessed duration of surgery, docking, placement of trocars and robotic manipulators, the need for their intraoperative displacement, incidence of intraoperative complications and conversions to laparoscopic surgery, intraoperative blood loss and early postoperative complications, severity of pain syndrome on the 1st day after surgery. Results. Mean surgery time was 87 [67, 120], 116 [78, 139], 96 [79, 125] and 141 [112, 184] min, respectively. Intraoperative blood loss was less than 50 ml. There were no complications requiring surgical treatment, cardiovascular, respiratory and other complications within 1 month. Conclusion. Robot-assisted bariatric surgery using the Senhance system is feasible and safe for patients. Immediate results of robotic surgery are comparable to those after laparoscopy. However, large experience and cost-effectiveness analysis are required to assess the feasibility of robotic systems in bariatric surgery.